IP Library Granted Patent US 9,234,188
Granted Patent B2
US 9,234,188 · App. 11/485,946 · Granted Jan 12, 2016

Modified zinc finger binding proteins

Inventors: Edward Rebar (El Cerrito, CA); Andrew Jamieson (San Francisco, CA)
Assignee: Sangamo BioSciences, Inc.
C12N9/1007C07K14/4702C12N15/8216C12N15/8217C12N15/8243A61K48/00C07K2319/00C07K2319/81
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,234,188
App. No.
11/485,946
Granted
Jan 12, 2016
Kind
B2
Abstract

Disclosed herein are compositions and method comprising non-canonical (e.g., non-C2H2) zinc finger proteins.

Claims (6)

1. A method of modulating expression of a gene in a plant cell or in an isolated mammalian cell, the method comprising the step of expressing, in the cell, a non-naturally-occurring zinc-finger binding protein comprising a non-canonical zinc finger comprising the sequence X 3 -Cys-X 2-4 -Cys-X 12 -His-X 1-7 -Z-X 4 (SEQ ID NO:121), where X is any amino acid and Z is C, where residues 6 to 12 of X 12 are engineered to bind to a target nucleic acid sequence, and wherein X 1-7 is selected from the group consisting of SETG (residues 2-5 of SEQ ID NO:12), LKSLTP (residues 2-7 of SEQ ID NO:13), SEN, VRI, KRS, KRL, LRW, ITT, IKG and IGG.

2. The method of claim 1 , wherein the non-naturally-occurring zinc-finger binding protein further comprises a functional domain.

3. The method of claim 2 , wherein the functional domain is an endonuclease.

4. The non-naturally occurring zinc finger binding proteins of claim 2 , wherein the functional domain is a repressive domain.

5. The non-naturally occurring zinc finger binding proteins of claim 2 , wherein the functional domain is an activation domain.

6. The method of claim 1 , wherein the gene is in a plant cell.

Assignments (1)
CHANGE OF NAME Recorded Sep 25, 2018
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 047639/0400 →
Continuity (4)
Division 10055711 · Jan 22, 2002
Provisional Application 60263445 · Jan 22, 2001
Provisional Application 60290716 · May 11, 2001
Related Publication 20060246588A1 · Nov 2, 2006